Mymetics Corp (MYMX)

[Work Harder]

The deal follows Intrexon's big dive into CAR-T, in which the company and partner Ziopharm ($ZIOP) are paying the University of

Texas MD Anderson Cancer Center $100 million to collaborate on

cancer therapies that modify patients' T cells.